IQVIA India has officially received its Contract Research Organization (CRO) registration from the Central Drugs Standard Control Organization (CDSCO) in April 2025, marking a significant milestone in the company’s commitment to regulatory excellence and clinical research leadership in India.

This registration aligns with the Indian government’s initiative to bring greater transparency and accountability to the CRO sector.

By mandating registration with CDSCO, the government aims to ensure high-quality, ethically conducted clinical trials that generate reliable data and foster global confidence in India’s research ecosystem.

IQVIA’s successful registration underscores its readiness to meet these elevated standards. The achievement was made possible through a coordinated effort by

See Full Page